Status:
COMPLETED
Titratable Dosing in Moderate to Severe Asthmatics
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the long term safety of Symbicort with budesonide alone, in adolescents and adults with asthma.
Eligibility Criteria
Inclusion
- Diagnosis of asthma and baseline lung function tests, symptoms and medication use as determined by the protocol
- Required and received treatment with inhaled corticosteroids within the timeframe and doses specified in the protocol
Exclusion
- Has required treatment with non-inhaled corticosteroids within previous 30 days, has sensitivity to drugs specified in the protocol or requires treatment with a beta-blocker.
- Has had cancer within previous 5 years or has a condition that may put the patient at risk in this study.
Key Trial Info
Start Date :
August 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2005
Estimated Enrollment :
570 Patients enrolled
Trial Details
Trial ID
NCT00651768
Start Date
August 1 2003
End Date
January 1 2005
Last Update
January 24 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.